A case of breast cancer in the axillary tail of Spence -enhanced magnetic resonance imaging and positron emission tomography for diagnostic differentiation and preoperative treatment decision

详细信息    查看全文

• 作者：Mai Okubo (1)
  Keiichiro Tada (1)
  Takayoshi Niwa (1)
  Kotoe Nishioka (1)
  Eiichi Tsuji (1)
  Toshihisa Ogawa (1)
  Yasuyuki Seto (1)
  
• 关键词：Breast neoplasms ; Axillary tail of spence ; MRI ; PET
• 刊名：World Journal of Surgical Oncology
• 出版年：2013
• 出版时间：December 2013
• 年：2013
• 卷：11
• 期：1
• 全文大小：363KB
• 参考文献：1. Ampil F, Caldito G, Henderson B, Li B, Kim RH, Burton G, Chu Q: Carcinoma of the axillary tail of spence: a case series. / Anticancer Res 2012, 32:4057-059.
  2. Memon S, Emanuel JC: The axillary tail–an important caveat in prophylactic mastectomy. / Breast J 2008, 14:313-14. CrossRef
  3. Agarwal G, Mishra SK, Dutta NR, Jain M: Occult squamous cell carcinoma of the axillary tail of breast presenting as isolated axillary lymph node mass. / Eur J Surg 2000, 166:177-79. CrossRef
  4. Chiari HH: Cancer in aberrant breast tissue. / Bruns Beitr Klin Chir 1958, 197:307-14.
  5. Sadler TW: / Langman's Medical Embryology. Baltimore: Williams & Wilkins; 1985.
  6. Marshall MB, Moynihan JJ, Frost A, Evans SR: Ectopic breast cancer: case report and literature review. / Surg Oncol 1994, 3:295-04. CrossRef
  7. Visconti G, Eltahir Y, Van Ginkel RJ, Bart J, Werker PM: Approach and management of primary ectopic breast carcinoma in the axilla: where are we? A comprehensive historical literature review. / J Plast Reconstr Aesthet Surg 2011, 64:e1-e11. CrossRef
  8. Pentheroudakis G, Lazaridis G, Pavlidis N: Axillary nodal metastases from carcinoma of unknown primary (CUPAx): a systematic review of published evidence. / Breast Canc Res Treat 2010, 119:1-1. CrossRef
  9. Copeland EM, McBride CM: Axillary metastases from unknown primary sites. / Ann Surg 1973, 178:25-7.
  10. Scoggins CR, Vitola JV, Sandler MP, Atkinson JB, Frexes-Steed M: Occult breast carcinoma presenting as an axillary mass. / Am Surg 1999, 65:1-.
  11. Abe H, Naitoh H, Umeda T, Shiomi H, Tani T, Kodama M, Okabe H: Occult breast cancer presenting axillary nodal metastasis: a case report. / Jpn J Clin Oncol 2000, 30:185-87. CrossRef
  12. Warner E, Plewes DB, Hill KA, Causer PA, Zubovits JT, Jong RA, Cutrara MR, DeBoer G, Yaffe MJ, Messner SJ, Meschino WS, Piron CA, Narod SA: Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. / JAMA 2004, 292:1317-325. CrossRef
  13. Kuhl CK, Schrading S, Leutner CC, Morakkabati-Spitz N, Wardelmann E, Fimmers R, Kuhn W, Schild HH: Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. / J Clin Oncol 2005, 23:8469-476. CrossRef
  14. Plevritis SK, Kurian AW, Sigal BM, Daniel BL, Ikeda DM, Stockdale FE, Garber AM: Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. / JAMA 2006, 295:2374-384. CrossRef
  15. Lehman CD, Gatsonis C, Kuhl CK, Hendrick RE, Pisano ED, Hanna L, Peacock S, Smazal SF, Maki DD, Julian TB, DePeri ER, Bluemke DA, Schnall MD, ACRIN Trial 6667 Investigators Group: MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. / N Engl J Med 2007, 356:1295-303. CrossRef
  16. Orel SG, Weinstein SP, Schnall MD, Reynolds CA, Schuchter LM, Fraker DL, Solin LJ: Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. / Radiology 1999, 212:543-49.
  17. de Bresser J, de Vos B, van der Ent F, Hulsewe K: Breast MRI in clinically and mammographically occult breast cancer presenting with an axillary metastasis: a systematic review. / Eur J Surg Oncol 2010, 36:114-19. CrossRef
  18. Kang BJ, Lee JH, Yoo Ie R, Kim SH, Choi JJ, Jeong SH, Yim HW: Clinical significance of incidental finding of focal activity in the breast at 18F-FDG PET/CT. / AJR Am J Roentgenol 2011, 197:341-47. CrossRef
  19. Litmanovich D, Gourevich K, Israel O, Gallimidi Z: Unexpected foci of 18F-FDG uptake in the breast detected by PET/CT: incidence and clinical significance. / Eur J Nucl Med Mol Imaging 2009, 36:1558-564. CrossRef
  
• 作者单位：Mai Okubo (1)
  Keiichiro Tada (1)
  Takayoshi Niwa (1)
  Kotoe Nishioka (1)
  Eiichi Tsuji (1)
  Toshihisa Ogawa (1)
  Yasuyuki Seto (1)
  
  1. Department of Breast and Endocrine Surgery, The University of Tokyo Hospital, Japan, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan
  

文摘

Background The management of cancer in the axillary area depends on the etiology of the tumor. Case Report A 37-year-old woman presented with a 2 cm mass in the axillary fossa. Core needle biopsy revealed adenocarcinoma. There were no abnormal breast findings on physical examination, mammography, or ultrasonography. However, enhanced magnetic resonance imaging (MRI) and positron emission tomography (PET) showed a segmentally-distributed, abnormal area in the upper-outer quadrant, continuous with the axillary mass. Samples of this area obtained by vacuum-assisted biopsy showed intraductal carcinoma. These findings indicated that the axillary lesion was a part of primary breast cancer originating from the axillary tail. Based on these results, the patient underwent total mastectomy with sentinel lymph node biopsy. Pathological examination of the specimen showed invasive ductal carcinoma accompanied by intraductal carcinoma extending up to 8.5 cm. Our case suggests that enhanced MRI and PET can provide useful preoperative information for the management of axillary breast lesions.